3c08
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[Image:3c08.png|left|200px]] | ||
| - | |||
{{STRUCTURE_3c08| PDB=3c08 | SCENE= }} | {{STRUCTURE_3c08| PDB=3c08 | SCENE= }} | ||
| - | |||
===Crystal structure the Fab fragment of matuzumab/EMD72000 (Fab72000)=== | ===Crystal structure the Fab fragment of matuzumab/EMD72000 (Fab72000)=== | ||
| - | |||
{{ABSTRACT_PUBMED_18394559}} | {{ABSTRACT_PUBMED_18394559}} | ||
| Line 14: | Line 10: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:018394559</ref><references group="xtra"/> | + | <ref group="xtra">PMID:018394559</ref><references group="xtra"/><references/> |
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: Ferguson, K M.]] | [[Category: Ferguson, K M.]] | ||
Revision as of 12:19, 24 March 2013
Contents |
Crystal structure the Fab fragment of matuzumab/EMD72000 (Fab72000)
Template:ABSTRACT PUBMED 18394559
About this Structure
3c08 is a 2 chain structure with sequence from Mus musculus. Full crystallographic information is available from OCA.
See Also
Reference
- Schmiedel J, Blaukat A, Li S, Knochel T, Ferguson KM. Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization. Cancer Cell. 2008 Apr;13(4):365-73. PMID:18394559 doi:10.1016/j.ccr.2008.02.019
